Home » Newsletters » BioWorld Science

BioWorld Science

April 24, 2000

View Archived Issues

BioQuest and Biovector Therapeutics to collaborate on HIV vaccine

Dura expands inhaler technology platform

Pharmacia to use Biacore's lead selection technology

Lundbeck and M&E Biotech to cooperate on neurodegenerative disease research

Humalog now available in Europe to treat children with diabetes

Idec enters two agreements for prostate cancer immunotherapy

Corixa receives milestone from Organon for RA collaboration

Raloxifene shows good uterine safety profile

Lilly and Arena to develop GPCRs as screening targets

Coley initiates phase I/II trials of CpG-7909 for cancer

Company Profile: Renovo

Apoptosis-initiating gene acquired by Idun

NIH research sheds light on chronic hepatitis C

CV Therapeutics develops sustained-release formulations of ranolazine

ATP-sensitive K+ channel blockers reportedly useful for vagal nervous system dysfunction

Novel compounds that inhibit hematopoietic cell activation in development at AstraZeneca

Immunomodulators from Gruenenthal affect IL-10 and IL-12 production

Aventis prepares new selective factor VIIa inhibitors

Preparation, activity and use of inhibitors of Th2-type cytokine production described by Sumitomo

Teveten now available in the U.K. for the treatment of hypertension

Anti-HIV activity demonstrated for natural product used in Japan for hepatitis

New controlled-release, microencapsulated HBV vaccine prepared in China

DepoMed reports phase I results for Metformin GR

Biovector Therapeutics initiates phase II trial of melanoma vaccine

Inhalable MS drug enters phase I trials

BMS temporarily withdraws Vanlev NDA

Artemis and Max Planck begin international genetic screening project with zebrafish

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...